Gov Data (VAERS) COVID Shows Shots have Caused 1,544,510 Adverse Events (288,607 Serious Injuries and 35,096 Deaths) VAERS Under Reports by a Factor of 4 to 5 times, w/an Accuracy Rate as Low as 1%
/
From [HERE] Data published Friday by the Vaccine Adverse Event Reporting System (VAERS) show 1,544,510 adverse events following COVID-19 vaccines were reported between Dec. 14, 2020, and April 7, 2023. This includes 288,607 reports of serious injuries and 35,096 deaths.
Of the 35,096 reported deaths, 21,905 cases are attributed to Pfizer, 9,920 to Moderna, 2,995 to Johnson & Johnson, and 18 to Novavax. Of the reported deaths, 9% occurred within 24 hours of vaccination, and 13% occurred within 48 hours.
VAERS is a voluntary reporting system co-managed by the U.S. Food and Drug Administration and Centers for Disease Control and Prevention (CDC) designed to detect vaccine safety signals.
In the U.S., 673 million COVID-19 vaccine doses had been administered as of March 27, including 401 million doses of Pfizer, 252 million doses of Moderna, 19 million doses of Johnson & Johnson, and 82,000 doses of Novavax.
Bivalent Booster Data
As of April 12, the CDC reported 55.5 million people had received an experimental bivalent booster dose targeting the no-longer-existing Wuhan strain and obsolete BA.4/BA.5 omicron subvariants.
Since the rollout of bivalent boosters in September 2022 and April 7, there have been 28,141 adverse events reported to VAERS, with 40% attributed to Moderna’s booster and 60% attributed to Pfizer/BioNTech. The data included 240 deaths, 2,187 serious injuries, and 80 reports of myocarditis and pericarditis (heart inflammation).
The CDC uses a narrowed case definition of myocarditis. To meet the case definition of myocarditis, people must have had “symptoms such as chest pain, shortness of breath and feelings of having a fast-beating, fluttering or pounding heart, and medical tests to support the diagnosis of myocarditis and rule out other causes.” This allows them to exclude cases of cardiac arrest, ischemic strokes, and deaths due to heart problems that occur before one has the chance to go to the hospital, obtain a diagnosis, or “dies suddenly.”
The CDC website does not state what happens to these cases, but there is no indication they are tracked or included in the CDC’s myocarditis numbers.
Data for 6-month-olds to 5-year-olds
6,122 adverse events, including 264 cases rated as serious and 14 reported deaths.
5 reports of myocarditis and pericarditis.
36 reports of blood clotting disorders, which means the CDC throttled at least 12 reports of blood clotting over the previous week.
61 reports of seizures.
Data for 5- to 11-year-olds
17,298 adverse events, including 840 rated as serious and 34 reported deaths.
48 reports of myocarditis and pericarditis.
76 reports of blood clotting disorders.
195 reports of seizures.
Data for 12- to 17-year-olds
41,692 adverse events, including 4,683 rated as serious and 140 reported deaths.
276 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment, or resulted in death.
1,357 reports of myocarditis and pericarditis, with 1,187 cases attributed to Pfizer’s vaccine.
313 reports of blood clotting disorders, with 285 cases attributed to Pfizer.
33 cases of postural orthostatic tachycardia syndrome (POTS) were attributed to Pfizer’s vaccine.
Data for all age groups to VAERS
16% of deaths were related to cardiac disorders.
53% of those who died were male, and 41% were female. The remaining death reports do not list the gender of the deceased.
The average age of death was 72.
As of April 7, 9,085 pregnant women reported adverse events related to COVID-19 vaccines, including 5,259 reports of miscarriage or premature birth.
Of the 17,209 cases of Bell’s palsy reported, 73% were attributed to Pfizer vaccinations, 22% to Moderna, and 5% to J&J.
3,293 reports of Guillain-Barré syndrome.
10,420 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
8,580 reports of myocardial infarction and cardiac arrest.
46,538 reports of blood-clotting disorders. Of those, 31,967 reports were attributed to Pfizer, 10,510 reports to Moderna, and 3,985 reports to Johnson & Johnson.
25,621 cases of myocarditis and pericarditis, with 19,461 cases attributed to Pfizer, 5,643 cases to Moderna, and 454 to Johnson & Johnson.
83 cases of Creutzfeldt-Jakob disease, with 67 cases attributed to Pfizer, 15 to Moderna, and 2 to J&J.
727 cases of POTS, with 538 cases attributed to Pfizer, 158 cases to Moderna, and 30 cases to Johnson & Johnson.
Although healthcare providers are required by law to report vaccine adverse events to VAERS, research shows very few do. It is essential that anyone who experiences an adverse event report their own injury.
